Trulieve Cannabis Corp. cash flow statement
In fiscal 2025, Trulieve Cannabis Corp.'s operations generated $273m of cash; it spent $44.2m on capital projects, leaving free cash flow of $229m.
Cash flow statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 19 | 100 | 13 | 23 | 202 | 271 | 273 | 244 |
| Depreciation and amortisation | 5 | 13 | 46 | 116 | 110 | 113 | 118 | 114 |
| Stock-based pay | — | 3 | 9 | 18 | 11 | 20 | 20 | 21 |
| Capital spending | 72 | 100 | 276 | 165 | 40 | 123 | 44 | 50 |
| Free cash flow | −53 | −0 | −263 | −142 | 162 | 149 | 229 | 194 |
| Free cash flow after stock pay | — | −3 | −272 | −160 | 151 | 129 | 208 | 173 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 30 | 31 | 51 | 86 | 76 | 59 | 56 | 53 |
| Depreciation and amortisation | 28 | 29 | 29 | 29 | 29 | 29 | 30 | 26 |
| Stock-based pay | 5 | 5 | 4 | 7 | 6 | 4 | 4 | 7 |
| Capital spending | 38 | 43 | 17 | 12 | 12 | 3 | 13 | 21 |
| Free cash flow | −8 | −12 | 34 | 75 | 64 | 56 | 42 | 32 |
| Free cash flow after stock pay | −13 | −17 | 30 | 68 | 58 | 52 | 38 | 25 |
Compare with peers
- Prestige Consumer Healthcare Inc. cash flow
- ANI Pharmaceuticals Inc cash flow
- Harmony Biosciences Holdings, Inc. cash flow
- Indivior Pharmaceuticals, Inc. cash flow
- Axsome Therapeutics, Inc. cash flow
Head to head: PBH vs TRLVANIP vs TRLVHRMY vs TRLVINDV vs TRLV
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies